 |
PDBsum entry 1md2
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Toxin
|
 |
|
Title:
|
 |
Cholera toxin b-pentamer with decavalent ligand bmsc-0013
|
|
Structure:
|
 |
Cholera toxin b subunit. Chain: d, e, f, g, h. Engineered: yes
|
|
Source:
|
 |
Vibrio cholerae. Organism_taxid: 666. Gene: ctxb. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Biol. unit:
|
 |
Pentamer (from
)
|
|
Resolution:
|
 |
|
1.45Å
|
R-factor:
|
0.125
|
R-free:
|
0.164
|
|
|
Authors:
|
 |
Z.Zhang,E.A.Merritt,M.Ahn,C.Roach,W.G.J.Hol,E.Fan
|
|
Key ref:
|
 |
Z.Zhang
et al.
(2002).
Solution and crystallographic studies of branched multivalent ligands that inhibit the receptor-binding of cholera toxin.
J Am Chem Soc,
124,
12991-12998.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
06-Aug-02
|
Release date:
|
11-Dec-02
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P01556
(CHTB_VIBCH) -
Cholera enterotoxin subunit B from Vibrio cholerae serotype O1 (strain ATCC 39315 / El Tor Inaba N16961)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
124 a.a.
104 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 2 residue positions (black
crosses)
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Am Chem Soc
124:12991-12998
(2002)
|
|
PubMed id:
|
|
|
|
|
| |
|
Solution and crystallographic studies of branched multivalent ligands that inhibit the receptor-binding of cholera toxin.
|
|
Z.Zhang,
E.A.Merritt,
M.Ahn,
C.Roach,
Z.Hou,
C.L.Verlinde,
W.G.Hol,
E.Fan.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The structure-based design of multivalent ligands offers an attractive strategy
toward high affinity protein inhibitors. The spatial arrangement of the
receptor-binding sites of cholera toxin, the causative agent of the severe
diarrheal disease cholera and a member of the AB(5) bacterial toxin family,
provides the opportunity of designing branched multivalent ligands with 5-fold
symmetry. Our modular synthesis enabled the construction of a family of complex
ligands with five flexible arms each ending with a bivalent ligand. The largest
of these ligands has a molecular weight of 10.6 kDa. These ligands are capable
of simultaneously binding to two toxin B pentamer molecules with high affinity,
thus blocking the receptor-binding process of cholera toxin. A more than
million-fold improvement over the monovalent ligand in inhibitory power was
achieved with the best branched decavalent ligand. This is better than the
improvement observed earlier for the corresponding nonbranched pentavalent
ligand. Dynamic light scattering studies demonstrate the formation of
concentration-dependent unique 1:1 and 1:2 ligand/toxin complexes in solution
with no sign of nonspecific aggregation. This is in complete agreement with a
crystal structure of the branched multivalent ligand/toxin B pentamer complex
solved at 1.45 A resolution that shows the specific 1:2 ligand/toxin complex
formation in the solid state. These results reiterate the power of the
structure-based design of multivalent protein ligands as a general strategy for
achieving high affinity and potent inhibition.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
D.Deniaud,
K.Julienne,
and
S.G.Gouin
(2011).
Insights in the rational design of synthetic multivalent glycoconjugates as lectin ligands.
|
| |
Org Biomol Chem,
9,
966-979.
|
 |
|
|
|
|
 |
P.Cheshev,
L.Morelli,
M.Marchesi,
C.Podlipnik,
M.Bergström,
and
A.Bernardi
(2010).
Synthesis and affinity evaluation of a small library of bidentate cholera toxin ligands: towards nonhydrolyzable ganglioside mimics.
|
| |
Chemistry,
16,
1951-1967.
|
 |
|
|
|
|
 |
R.Maheshwari,
E.A.Levenson,
and
K.L.Kiick
(2010).
Manipulation of electrostatic and saccharide linker interactions in the design of efficient glycopolypeptide-based cholera toxin inhibitors.
|
| |
Macromol Biosci,
10,
68-81.
|
 |
|
|
|
|
 |
S.P.Liu,
L.Zhou,
R.Lakshminarayanan,
and
R.W.Beuerman
(2010).
Multivalent Antimicrobial Peptides as Therapeutics: Design Principles and Structural Diversities.
|
| |
Int J Pept Res Ther,
16,
199-213.
|
 |
|
|
|
|
 |
C.Sisu,
A.J.Baron,
H.M.Branderhorst,
S.D.Connell,
C.A.Weijers,
R.de Vries,
E.D.Hayes,
A.V.Pukin,
M.Gilbert,
R.J.Pieters,
H.Zuilhof,
G.M.Visser,
and
W.B.Turnbull
(2009).
The influence of ligand valency on aggregation mechanisms for inhibiting bacterial toxins.
|
| |
Chembiochem,
10,
329-337.
|
 |
|
|
|
|
 |
R.J.Pieters
(2009).
Maximising multivalency effects in protein-carbohydrate interactions.
|
| |
Org Biomol Chem,
7,
2013-2025.
|
 |
|
|
|
|
 |
S.Menon,
K.Rosenberg,
S.A.Graham,
E.M.Ward,
M.E.Taylor,
K.Drickamer,
and
D.E.Leckband
(2009).
Binding-site geometry and flexibility in DC-SIGN demonstrated with surface force measurements.
|
| |
Proc Natl Acad Sci U S A,
106,
11524-11529.
|
 |
|
|
|
|
 |
G.Zhang
(2008).
Design, synthesis, and evaluation of bisubstrate analog inhibitors of cholera toxin.
|
| |
Bioorg Med Chem Lett,
18,
3724-3727.
|
 |
|
|
|
|
 |
J.Liu,
D.Begley,
D.D.Mitchell,
C.L.Verlinde,
G.Varani,
and
E.Fan
(2008).
Multivalent drug design and inhibition of cholera toxin by specific and transient protein-ligand interactions.
|
| |
Chem Biol Drug Des,
71,
408-419.
|
 |
|
|
|
|
 |
L.Wang,
F.Kong,
C.L.Kokoski,
D.W.Andrews,
and
C.Xing
(2008).
Development of dimeric modulators for anti-apoptotic Bcl-2 proteins.
|
| |
Bioorg Med Chem Lett,
18,
236-240.
|
 |
|
|
|
|
 |
M.K.O'Reilly,
B.E.Collins,
S.Han,
L.Liao,
C.Rillahan,
P.I.Kitov,
D.R.Bundle,
and
J.C.Paulson
(2008).
Bifunctional CD22 ligands use multimeric immunoglobulins as protein scaffolds in assembly of immune complexes on B cells.
|
| |
J Am Chem Soc,
130,
7736-7745.
|
 |
|
|
|
|
 |
S.Liu,
and
K.L.Kiick
(2008).
Architecture Effects on the Binding of Cholera Toxin by Helical Glycopolypeptides.
|
| |
Macromolecules,
41,
764-772.
|
 |
|
|
|
|
 |
A.V.Pukin,
H.M.Branderhorst,
C.Sisu,
C.A.Weijers,
M.Gilbert,
R.M.Liskamp,
G.M.Visser,
H.Zuilhof,
and
R.J.Pieters
(2007).
Strong inhibition of cholera toxin by multivalent GM1 derivatives.
|
| |
Chembiochem,
8,
1500-1503.
|
 |
|
|
|
|
 |
B.D.Polizzotti,
R.Maheshwari,
J.Vinkenborg,
and
K.L.Kiick
(2007).
Effects of Saccharide Spacing and Chain Extension on Toxin Inhibition by Glycopolypeptides of Well-Defined Architecture.
|
| |
Macromolecules,
40,
7103-7110.
|
 |
|
|
|
|
 |
H.M.Branderhorst,
R.M.Liskamp,
G.M.Visser,
and
R.J.Pieters
(2007).
Strong inhibition of cholera toxin binding by galactose dendrimers.
|
| |
Chem Commun (Camb),
(),
5043-5045.
|
 |
|
|
|
|
 |
J.M.Belitsky,
A.Nelson,
J.D.Hernandez,
L.G.Baum,
and
J.F.Stoddart
(2007).
Multivalent interactions between lectins and supramolecular complexes: Galectin-1 and self-assembled pseudopolyrotaxanes.
|
| |
Chem Biol,
14,
1140-1151.
|
 |
|
|
|
|
 |
A.Joshi,
A.Saraph,
V.Poon,
J.Mogridge,
and
R.S.Kane
(2006).
Synthesis of potent inhibitors of anthrax toxin based on poly-L-glutamic acid.
|
| |
Bioconjug Chem,
17,
1265-1269.
|
 |
|
|
|
|
 |
L.L.Kiessling,
J.E.Gestwicki,
and
L.E.Strong
(2006).
Synthetic multivalent ligands as probes of signal transduction.
|
| |
Angew Chem Int Ed Engl,
45,
2348-2368.
|
 |
|
|
|
|
 |
C.Zubieta,
G.Schoehn,
J.Chroboczek,
and
S.Cusack
(2005).
The structure of the human adenovirus 2 penton.
|
| |
Mol Cell,
17,
121-135.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.G.Ho,
P.I.Kitov,
E.Paszkiewicz,
J.Sadowska,
D.R.Bundle,
and
K.K.Ng
(2005).
Ligand-assisted aggregation of proteins. Dimerization of serum amyloid P component by bivalent ligands.
|
| |
J Biol Chem,
280,
31999-32008.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.T.Schuman,
J.S.Grinstead,
V.Apostolopoulos,
and
A.P.Campbell
(2005).
Structural and dynamic consequences of increasing repeats in a MUC1 peptide tumor antigen.
|
| |
Biopolymers,
77,
107-120.
|
 |
|
|
|
|
 |
A.Holmner,
M.Lebens,
S.Teneberg,
J.Angström,
M.Okvist,
and
U.Krengel
(2004).
Novel binding site identified in a hybrid between cholera toxin and heat-labile enterotoxin: 1.9 A crystal structure reveals the details.
|
| |
Structure,
12,
1655-1667.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.E.Collins,
and
J.C.Paulson
(2004).
Cell surface biology mediated by low affinity multivalent protein-glycan interactions.
|
| |
Curr Opin Chem Biol,
8,
617-625.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |